about
Mitochondrial Redox Signaling and Tumor ProgressionMitochondria in Cancer Energy Metabolism: Culprits or Bystanders?From obesity to diabetes and cancer: epidemiological links and role of therapiesCancer Metabolism and Drug ResistanceThe placenta: a multifaceted, transient organROS homeostasis and metabolism: a critical liaison for cancer therapyLarge oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles.Structural mass spectrometry of tissue extracts to distinguish cancerous and non-cancerous breast diseases.Mitochondrial DNA somatic mutation in cancerHyperpolarized 13C MR for molecular imaging of prostate cancer.Real-time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor.3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.Redox control of enzymatic functions: The electronics of life's circuitry.Drug-induced amino acid deprivation as strategy for cancer therapy.miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion.Metal complexes in cancer therapy - an update from drug design perspective.Development of high resolution 3D hyperpolarized carbon-13 MR molecular imaging techniques.Obesity and Risk of Cancer: An Introductory Overview.Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells.Down-regulation of PDK4 is Critical for the Switch of Carbohydrate Catabolism during Syncytialization of Human Placental Trophoblasts.Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancerPreface to the column "Metabolism of Childhood Cancer".Prediction of mycoplasma hominis proteins targeting in mitochondria and cytoplasm of host cells and their implication in prostate cancer etiology.The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer.Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.CHO Cells adapted to inorganic phosphate limitation show higher growth and higher pyruvate carboxylase flux in phosphate replete conditions.Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia.Glutamine metabolism, the Achilles heel for medulloblastoma tumor.Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells.DNA Damage, Repair, and Cancer Metabolism.Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival.Essential amino acid mixtures drive cancer cells to apoptosis through proteasome inhibition and autophagy activation.Revisiting the Crabtree/Warburg effect in a dynamic perspective: a fitness advantage against sugar-induced cell death.Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL.TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor.
P2860
Q26749592-3E8DD111-AB16-4489-8705-3924F2E6C918Q26766062-C26B498F-7B82-4357-B041-4BD5E4EAA823Q26767027-D259C5BC-D890-40D3-9A42-F21D827D5740Q26782042-49FC1840-FD1D-4D41-8020-058302453F6BQ27687553-FF7B0741-CE3B-43A6-BE89-06F322C0E9D0Q28080316-E6413434-25F1-48C3-974C-5A6EFEA06CF0Q30655972-F73F839A-561A-4CFD-93F8-FD853083158BQ34282970-7C90279D-5C54-4D15-AC55-51085F11EF57Q34906440-F38392C5-76F4-43FB-AB7D-DCA18D81B7B2Q35146434-172AB7E5-3A22-4B48-980C-2B36D0148548Q35958087-F2F95162-B06D-46A1-A0C0-26A525931D3BQ36330235-BDBDD597-B8C9-4F2D-A142-8F9E221774B7Q38199448-C0A43A07-B895-4C26-BF6B-6B7AE0A9FE87Q38657061-5A48E671-854F-4C57-A63D-5C12E4453DA2Q38657851-BA287B4F-E841-4D44-95AE-DCBDCFC8EA97Q38692500-DB8314D5-D631-4B3E-980F-3433A6C757BCQ38692975-879BB66F-D4CB-492D-9BE2-642C83048658Q38771736-2BEB8D0E-E9C3-4FAB-8C18-D4E6A9D5F773Q38788254-1E02AD0D-7B72-4C59-A942-B3277EEC2E6DQ38928346-68F007E4-208B-476E-8FDD-8C5220709977Q41436935-1F030B59-C7B1-485E-AE71-547FF4642B96Q41472442-6C6324F5-C15B-4E0F-82FC-FF8BE3878CDFQ41811936-D8CC14FD-24A2-4C27-8158-46AC00E319BBQ42199068-99E2CB24-5B8C-42A7-BC7F-E40D9A83C448Q42217101-42F56B12-B670-4458-A7DE-19589C3DBEFEQ45943755-9E44DC47-84A9-4DCF-B247-6801654E07C2Q46414822-B81F4A9A-FF6B-4006-A769-0EF375BFDC8DQ48057726-A4CDEAE8-95B4-49D7-B69F-8FA4E9F1C395Q48190229-6CDE12F0-8A01-42CB-B401-AFB546B525A5Q49307514-1B0F1203-BBAB-4A7E-A4EE-173FA6D58E73Q49829014-78A4EEC4-B5BE-4FD3-AA81-25CC9BAC6551Q50055579-6A2C3010-492B-4F9C-A49F-387A53E2A00BQ50660795-28D7EC37-F027-4649-82E9-EADCBEB62373Q51149489-2AA4CDC9-2FB8-4146-B229-B063AC24902FQ52372502-A15EFD90-AF90-4927-B12C-B87CE431ACF5Q53698115-27B07546-CA63-48A4-9082-C7F4529324A6
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Is cancer a metabolic disease?
@ast
Is cancer a metabolic disease?
@en
Is cancer a metabolic disease?
@nl
type
label
Is cancer a metabolic disease?
@ast
Is cancer a metabolic disease?
@en
Is cancer a metabolic disease?
@nl
prefLabel
Is cancer a metabolic disease?
@ast
Is cancer a metabolic disease?
@en
Is cancer a metabolic disease?
@nl
P2860
P3181
P1476
Is cancer a metabolic disease?
@en
P2093
Hilary A. Coller
P2860
P3181
P356
10.1016/J.AJPATH.2013.07.035
P407
P577
2014-01-01T00:00:00Z